Effective mosaic-based nanovaccines against avian influenza in poultry.

[1]  S. Bourgault,et al.  Nanoparticle-Based Vaccines Against Respiratory Viruses , 2019, Front. Immunol..

[2]  Lei Deng,et al.  Universal influenza vaccines: from viruses to nanoparticles , 2018, Expert review of vaccines.

[3]  B. Narasimhan,et al.  Surface engineered polyanhydride-based oral Salmonella subunit nanovaccine for poultry , 2018, International journal of nanomedicine.

[4]  D. Kapczynski,et al.  Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens. , 2018, Vaccine.

[5]  B. Narasimhan,et al.  Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections , 2018, Front. Immunol..

[6]  Florian Krammer,et al.  Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies , 2018, Nature Communications.

[7]  Christopher D Spicer,et al.  Peer-reviewed version of the manuscript published in final form at Chemical Society Reviews (2018) Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications , 2018 .

[8]  B. Narasimhan,et al.  Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity , 2018, Front. Immunol..

[9]  B. Narasimhan,et al.  Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf , 2018, Scientific Reports.

[10]  K. Broman,et al.  A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques , 2017, PloS one.

[11]  K. Kang,et al.  Polyanhydride nanovaccine against swine influenza virus in pigs. , 2017, Vaccine.

[12]  J. Gelb,et al.  Efficacy of Recombinant HVT-IBD Vaccines Administered to Broiler Chicks from a Single Breeder Flock at 30 and 60 Weeks of Age , 2016, Avian Diseases.

[13]  J. Osorio,et al.  Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses , 2016, Journal of Virology.

[14]  M. Shi,et al.  Diversity and evolution of avian influenza viruses in live poultry markets, free-range poultry and wild wetland birds in China. , 2016, The Journal of general virology.

[15]  P. Hosseini,et al.  Genetically Diverse Low Pathogenicity Avian Influenza A Virus Subtypes Co-Circulate among Poultry in Bangladesh , 2016, PloS one.

[16]  R. Booy,et al.  Mismatching between circulating strains and vaccine strains of influenza: Effect on Hajj pilgrims from both hemispheres , 2016, Human vaccines & immunotherapeutics.

[17]  Justin R. Adams,et al.  Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza. , 2016, ACS biomaterials science & engineering.

[18]  D. Suarez,et al.  Poultry vaccination directed evolution of H9N2 low pathogenicity avian influenza viruses in Korea. , 2016, Virology.

[19]  A. Read,et al.  Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens , 2015, PLoS biology.

[20]  D. Kapczynski,et al.  Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus. , 2015, Vaccine.

[21]  M. Jhung,et al.  Outbreaks of Avian Influenza A (H5N2), (H5N8), and (H5N1) Among Birds — United States, December 2014–January 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[22]  S. Carpenter,et al.  Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity , 2014, International journal of nanomedicine.

[23]  D. Swayne,et al.  Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies , 2014, Veterinary Research.

[24]  Tavis K. Anderson,et al.  Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene , 2014, Journal of Virology.

[25]  D. Stallknecht,et al.  Subtype diversity and reassortment potential for co-circulating avian influenza viruses at a diversity hot spot. , 2014, The Journal of animal ecology.

[26]  E. Holmes,et al.  Emergence of a Highly Pathogenic Avian Influenza Virus from a Low-Pathogenic Progenitor , 2014, Journal of Virology.

[27]  M. Killian.  Hemagglutination assay for influenza virus. , 2014, Methods in molecular biology.

[28]  B. Narasimhan,et al.  Safety and Biocompatibility of Carbohydrate-Functionalized Polyanhydride Nanoparticles , 2014, The AAPS Journal.

[29]  R. Webster,et al.  Natural history of highly pathogenic avian influenza H5N1. , 2013, Virus research.

[30]  B. Narasimhan,et al.  Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles. , 2013, Acta biomaterialia.

[31]  C. Davis,et al.  A High Diversity of Eurasian Lineage Low Pathogenicity Avian Influenza A Viruses Circulate among Wild Birds Sampled in Egypt , 2013, PloS one.

[32]  B. Narasimhan,et al.  Evaluation of Biocompatibility and Administration Site Reactogenicity of Polyanhydride‐Particle‐Based Platform for Vaccine Delivery , 2013, Advanced healthcare materials.

[33]  B. Narasimhan,et al.  Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses. , 2013, Journal of biomedical materials research. Part B, Applied biomaterials.

[34]  S. Plotkin,et al.  Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. , 2012, Vaccine.

[35]  Low-pathogenic avian influenza virus A/turkey/Ontario/6213/1966 (H5N1) is the progenitor of highly pathogenic A/turkey/Ontario/7732/1966 (H5N9). , 2012, The Journal of general virology.

[36]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[37]  Theo M Bestebroer,et al.  Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets , 2012, Science.

[38]  P. Wilson,et al.  Targeting B cell responses in universal influenza vaccine design. , 2011, Trends in immunology.

[39]  A. García-Sastre,et al.  Influenza A viruses: new research developments , 2011, Nature Reviews Microbiology.

[40]  B. Narasimhan,et al.  Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases , 2011, PloS one.

[41]  S. Mittal,et al.  Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses , 2010, Human vaccines.

[42]  B. Narasimhan,et al.  Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[43]  P. Wright.  Vaccine preparedness--are we ready for the next influenza pandemic? , 2008, The New England journal of medicine.

[44]  H. Ehrlich,et al.  A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. , 2008, The New England journal of medicine.

[45]  T. Mettenleiter,et al.  Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. , 2008, Vaccine.

[46]  J. Lowenthal,et al.  ELISPOT and intracellular cytokine staining: novel assays for quantifying T cell responses in the chicken. , 2008, Developmental and comparative immunology.

[47]  Balaji Narasimhan,et al.  Amphiphilic polyanhydrides for protein stabilization and release. , 2007, Biomaterials.

[48]  M. Feinberg,et al.  Differences and Similarities in Viral Life Cycle Progression and Host Cell Physiology after Infection of Human Dendritic Cells with Modified Vaccinia Virus Ankara and Vaccinia Virus , 2006, Journal of Virology.

[49]  Balaji Narasimhan,et al.  Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. , 2006, Journal of biomedical materials research. Part A.

[50]  Wentao Gao,et al.  Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization , 2006, Journal of Virology.

[51]  I. Brown,et al.  Recombination Resulting in Virulence Shift in Avian Influenza Outbreak, Chile , 2004, Emerging infectious diseases.

[52]  R. Cox,et al.  Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines , 2004, Scandinavian journal of immunology.

[53]  I. Capua,et al.  Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy , 2001, Archives of Virology.

[54]  Tokiko Watanabe,et al.  Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Maricarmen García,et al.  Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. , 1999, Vaccine.

[56]  R. Webster,et al.  Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. , 1995, Virology.

[57]  H. Stone.  Efficacy of avian influenza oil-emulsion vaccines in chickens of various ages. , 1987, Avian diseases.

[58]  W. J. Bean,et al.  Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature , 1985, Journal of virology.

[59]  P. Wright,et al.  Behavior of Vaccine Revertants of Temperature-Sensitive Mutants of Influenza Virus in Ferret Tracheal Organ Culture , 1979, Infection and immunity.